ArticleWorld journal of transplantation2025
Introducing hyperspectral imaging as a novel tool for assessing donor liver quality during machine perfusion: A case report.
Article in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperspectral imaging (HSI) offers useful information on organ quality and has already been successfully used in kidney and liver transplantation to assess transplanted organs. Up to now, there is no case report in the literature describing HSI for quality assessment of a machine perfused donor liver. The allocated liver from a 49-year-old female donor (161 cm, 70 kg) was perfused with the OrganOx CASE SUMMARY: The donor liver's size (29 cm × 17 cm × 11 cm) and weight of 2180 g posed challenges for adequate placement within the organ container. Baseline biopsy of the liver revealed no evidence of fibrosis, steatosis or inflammation. An hour after perfusion start, measurements of the perfusate indicated a pH of 7.18, a glucose level of 404 mg/dL, and a lactate level of 1.7 mmol/L. Throughout perfusion, a significant decline in glucose levels began at the fourth hour, reaching a nadir of 20 mg/dL after eight hours. Concurrently, lactate levels steadily rose, peaking at 4.9 mmol/L after the total perfusion time of 12 hours. Macroscopic alterations (signs of congestion and reduced blood circulation) on the liver's surface were noted, particularly pronounced in segments 2, 3, and 8. HSI of these areas unveiled significant reduced oxygenation. Consequently, based on all these observations, the decision was made to discard the organ. Histological examination of the altered regions revealed congestion, necrotic changes, and dissociation of sinusoidal lining cells from liver cell cords. The histological findings correlated well with the HSI.
conclusionThis case report describes the integration of HSI in the decision making of the decline of a 49-year-old machine perfused donor liver. HSI offered useful information concerning the tissue morphology and graft viability and could therefore be a useful additional tool in assessing donor liver quality before transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.